CRISPR Therapeutics · CH0334081137 · CRSP | XNAS | Prime AI Terminal

CUSIP

033408113

SEDOL

BD45MY9

CIK

0001674416

www.crisprtx.com

LEI:

CRISPR Therapeutics is a Member of Themefolio

G. Orwell

CRISPR Therapeutics AG

BASIC = Free ADVANCED = User Account BUSINESS = Subscription PRIME = Subscription

ENTERPRISE = upon request

PROFILER

BASIC

ADVANCED

BUSINESS

PRIME

AI Insights

CRISPR Therapeutics

Click to initiate

ENTERPRISE

Securities Trading Warrants

From this overview you can obtain a wide range of company-specific data, primarily relating to the stock exchange listing and the associated identification in securities trading. If you need this and other information for other companies, you will find it here.

https://ayon.do/ts/A2AT0Z

Smart Investor

Terminal

A
#	ID/ variable / content type	Security-specific parameter	UID	KB
1	ISIN INTERNATIONAL SECURITY IDENTIFICATION NUMBER	CH0334081137		Link
2	FIGI Financial Instrument Global Identifier®	BBG00DBBGRX1		-
3	CIK Central Index Key	0001674416		Link
4	WKN WERTPAPIERKENNUMMER	A2AT0Z		Link
5	SEDOL Stock Exchange Daily Official List	BD45MY9		Link
6	CUSIP Committee on Uniform Securities Identification Procedures	033408113		Link
7	BLOOMBERG (default) BLOOMBERG IDENTIFIER	CRSP US		Link
8	RIC REUTERS/REFINITY IDENTIFIER	CRSP.OQ		Link
9	MNEMONIC ABBREVIATION CODE	-		Link
10	TICKER TICKER	-		Link
11	SYMBOL SYMBOL	CRSP		Link
12	TDIM Tradable Instrument Display Mnemonic	-		Link
13	MIC MARKET IDENTIFIER CODE	XNAS		Link
14	DSX DOMESTIC STOCK EXCHANGE	NASDAQ		Link
15	LEI LEGAL IDENTIFIER	-		Link
16	Valor Valor	-		-
17	CRN COMMERCIAL REGISTER NUMBER	-		Link
18	DNB-ID DUN & BRADSTREET	487155645		Link
19	VAT-ID VALUE ADDED TAX ID	-		-
20	GICS Global Industry Classification Standard®	-		-
21	Sector assignment GICS® Sector assignment	Healthcare		-
22	TradingView® Symbol TradingView® Symbol	NASDAQ:CRSP		-

www.crisprtx.com

Smart Investor

Terminal

B
#	ID/ variable / content type	Security-specific parameter	UID	KB
1	SHORT NAME -	CRISPR Therapeutics		-
2	LEGAL ENTITY NAME -	-		-
3	SECURITY NAME -	CRISPR Therapeutics AG		-
4	NICKNAME -	-		-
5	PREVIOUS NAME -	-		-

Smart Investor

Terminal

C
#	ID/ variable / content type	Security-specific parameter	UID	KB
1	COUNTRY OF ORGIN	Switzerland		-
2	ISO CODE 2 DIGIT ISO CODE	CH		-
3	ISO CODE 3 DIGIT ISO CODE	CHE		-
4	COUNTRY FLAG COUNTRY COLOUR CODE			-

Research & Analysis

We are different

OPEN FINANCIAL

DATA & KNOWLEDGE HUB

We make the difference

Information on product placements

SMART * AD

P R O D U C T S U G G E S T I O N S

Subject *

i.e Feature x is not working

Issue happened on *

This page

Other page

Page URL

Paste the page URL here

Bug Detail *

Please give us more detailed explanation of the issue

Steps to reproduce *

Specify the steps you've done before the issue happen

Actual Result *

What's the result of the issue?

Expected Result *

What do you expect to see?

Attachment

(Optional) You can send us a screenshot, word document, or a PDF explaining the issue

You have pressed the "". We would like to inform you that you are now leaving the information service of the portal site ayondo.com. You will be redirected to . After confirming the "Continue" button, you confirm that you have been informed of this. You also confirm that you are carrying out this process of your own free will and that it is not the result of any promotional activity or other influence. Continue to .

I would like to remain anonymous.

Subject *

e.g. New calculation method for Risk-of-Ruin-Calculator

View/Tool *

This view/tool

Another page/tool

Description of the proposed change/feedback *

The more comprehensible the description, the faster a feasibility check can be carried out.

General feedback on the view/tool/component/content *

Use this feedback text field for general or supplementary information

Would you use the tool and recommend it if necessary? *

Your opinion is valuable. Feel free to share it with us.

CRISPR Therapeutics AG

Newsletter